Globus Medical, Inc. (NYSE: GMED) is a Healthcare company (Medical - Devices) with a market capitalization of $9.3B. The Maz Rating grades it against the other companies in its sector.
Globus Medical, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $69.99, Globus Medical, Inc. trades at 17.0x trailing earnings, 3.0x sales and 2.0x book value, with an EV/EBITDA of 9.1. Over the last twelve months it generated about $3.1B of revenue and $546M of net income. It runs a gross margin of 70.1%, an operating margin of 22.1% and a net margin of 17.8%. It shows return on equity of 11.8%, return on invested capital of 10.9% and a free cash flow yield of 8.1%. On the balance sheet: a debt-to-equity ratio of 0.02 and a current ratio of 4.30. Over the past 52 weeks the share price ranged from $69.49 to $101.40, with a beta of 0.96.
Globus Medical, Inc. does not currently pay a dividend.
37 Wall Street analyst ratings cover the stock: 26 Buy, 10 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.